Product
Telotristat Etiprate
1 clinical trial
2 indications
Indication
Carcinoid SyndromeClinical trial
Monitoring Telotristat Ethyl Inhibition of Tryptophan Hydroxylase (TPH) in Neuroendocrine Tumors Using ?-[11C]Methyl-L-tryptophan (AMT)-PETStatus: Recruiting, Estimated PCD: 2023-10-01